490 related articles for article (PubMed ID: 16755657)
1. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
[TBL] [Abstract][Full Text] [Related]
2. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus.
Klapper W; Moosig F; Sotnikova A; Qian W; Schröder JO; Parwaresch R
Ann Rheum Dis; 2004 Dec; 63(12):1681-3. PubMed ID: 15547095
[TBL] [Abstract][Full Text] [Related]
4. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus.
Honda M; Mengesha E; Albano S; Nichols WS; Wallace DJ; Metzger A; Klinenberg JR; Linker-Israeli M
Clin Immunol; 2001 May; 99(2):211-221. PubMed ID: 11318593
[TBL] [Abstract][Full Text] [Related]
5. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T
Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
[TBL] [Abstract][Full Text] [Related]
6. Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity.
Wu CH; Hsieh SC; Li KJ; Lu MC; Yu CL
Lupus; 2007; 16(4):265-72. PubMed ID: 17439933
[TBL] [Abstract][Full Text] [Related]
7. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
9. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
11. Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH.
Beier F; Balabanov S; Amberger CC; Hartmann U; Manger K; Dietz K; Kötter I; Brummendorf TH
Lupus; 2007; 16(12):955-62. PubMed ID: 18042589
[TBL] [Abstract][Full Text] [Related]
12. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
15. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
[TBL] [Abstract][Full Text] [Related]
16. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
19. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H
J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
[TBL] [Abstract][Full Text] [Related]
20. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
